New Trends in Cancer for the 21st Century: Proceedings of the International Symposium on Cancer: New Trends in Cancer for the 21st Century, held November 10–13, 2002, in Valencia, Spain: Advances in Experimental Medicine and Biology, cartea 532
Editat de Antonio Llombart-Bosch, Vicente Felipoen Limba Engleză Paperback – 12 oct 2012
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 359.45 lei 6-8 săpt. | |
Springer Us – 12 oct 2012 | 359.45 lei 6-8 săpt. | |
Hardback (1) | 563.13 lei 6-8 săpt. | |
Springer Verlag – 30 iul 2003 | 563.13 lei 6-8 săpt. |
Din seria Advances in Experimental Medicine and Biology
- 70% Preț: 237.22 lei
- 5% Preț: 695.23 lei
- 5% Preț: 689.90 lei
- 15% Preț: 617.15 lei
- 5% Preț: 689.20 lei
- 5% Preț: 991.95 lei
- 5% Preț: 690.08 lei
- Preț: 642.95 lei
- 5% Preț: 239.86 lei
- 5% Preț: 820.42 lei
- 5% Preț: 688.32 lei
- 5% Preț: 1081.86 lei
- 15% Preț: 621.90 lei
- 5% Preț: 689.90 lei
- 5% Preț: 695.76 lei
- 20% Preț: 691.93 lei
- 20% Preț: 1117.65 lei
- 5% Preț: 1136.90 lei
- 18% Preț: 1077.43 lei
- 5% Preț: 1239.61 lei
- 5% Preț: 1120.53 lei
- 5% Preț: 1059.99 lei
- 18% Preț: 1081.06 lei
- 5% Preț: 1381.19 lei
- 20% Preț: 1004.51 lei
- 18% Preț: 919.23 lei
- 18% Preț: 252.54 lei
- 18% Preț: 921.32 lei
- 18% Preț: 1188.87 lei
- 5% Preț: 1184.85 lei
- 5% Preț: 395.78 lei
- 5% Preț: 1070.46 lei
- 18% Preț: 1089.86 lei
- 5% Preț: 1121.03 lei
- 5% Preț: 1377.73 lei
- 14% Preț: 1137.13 lei
- 18% Preț: 1363.93 lei
- 18% Preț: 1359.38 lei
- 24% Preț: 806.15 lei
- 18% Preț: 1207.57 lei
- 5% Preț: 1388.37 lei
- 5% Preț: 1557.29 lei
- 5% Preț: 1255.63 lei
- 18% Preț: 1092.61 lei
- 14% Preț: 955.92 lei
- 15% Preț: 631.25 lei
- 5% Preț: 1055.95 lei
- 18% Preț: 909.95 lei
Preț: 359.45 lei
Preț vechi: 378.37 lei
-5% Nou
Puncte Express: 539
Preț estimativ în valută:
68.79€ • 72.57$ • 57.33£
68.79€ • 72.57$ • 57.33£
Carte tipărită la comandă
Livrare economică 03-17 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9781461349143
ISBN-10: 1461349141
Pagini: 308
Ilustrații: X, 293 p.
Dimensiuni: 178 x 254 x 16 mm
Greutate: 0.54 kg
Ediția:Softcover reprint of the original 1st ed. 2003
Editura: Springer Us
Colecția Springer
Seria Advances in Experimental Medicine and Biology
Locul publicării:New York, NY, United States
ISBN-10: 1461349141
Pagini: 308
Ilustrații: X, 293 p.
Dimensiuni: 178 x 254 x 16 mm
Greutate: 0.54 kg
Ediția:Softcover reprint of the original 1st ed. 2003
Editura: Springer Us
Colecția Springer
Seria Advances in Experimental Medicine and Biology
Locul publicării:New York, NY, United States
Public țintă
Professional/practitionerCuprins
Driving the Cell Cycle to Cancer.- Proliferation: The Cell Cycle.- Molecular Analysis of Gene Expression in Tumor Pathology.- Ewing Tumor Biology: Perspectives for Innovative Treatment Approaches.- Cancer Epigenetics: DNA Methylation and Chromatin Alterations in Human Cancer.- Molecular Analysis of Cancer Using DNA and Protein Microarrays.- Proteomic Approaches to the Diagnosis, Treatment, and Monitoring of Cancer.- Structural Basis of Tumoral Angiogenesis.- Matrix Metalloproteinases and Tumor Progression.- Angiogenesis Inhibitors and Their Therapeutic Potentials.- Mutated Tyrosine Kinases as Therapeutic Targets in Myeloid Leukemias.- Targeting PDGF Receptors in Cancer-Rationales and Proof of Concept Clinical Trials.- Immune-Promoted Tumor Cell Invasion and Metastasis. New considerations in cancer therapy.- Improvements of Survival in Nine Phase II Clinical Studies With Different Types of Cancer Upon Anti-Tumor Vaccination with an Autologous Tumor Cell Vaccine Modified by Virus Infection to Introduce Danger Signals.- Causation and Prevention of Solely Estrogen-Induced Oncogenesis: Similarities to Human Ductal Breast Cancer.- Cyclooxygenase-2 Inhibitors in Cancer Prevention and Treatment.- Exosomes for Immunotherapy of Cancer.- Breast Cancer Gene Expression Analysis ¡ª The Case for Dynamic Profiling..- Development of the Epidermal Growth Factor Receptor Inhibitor TARCEVATm (OSI-774).- Gefitinib (TRESSA, ZD 1839) for Non-Small Cell Lung Cancer (NSCLC): Recents Results and Further Strategies.- Mechanism of Action of Anti-HER2 Monoclonal Antibodies: Scientific Update on Trastuzumab and 2C4.- EORTC Research and Development: Achievements and Future Perspectives.- Contributors.